AXON vs. NVCR: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at AXON and NVCR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | AXON | NVCR |
|---|---|---|
| Company Name | Axon Enterprise, Inc. | NovoCure Limited |
| Country | United States | Switzerland |
| GICS Sector | Industrials | Health Care |
| GICS Industry | Aerospace & Defense | Health Care Equipment & Supplies |
| Market Capitalization | 59.94 billion USD | 1.31 billion USD |
| Exchange | NasdaqGS | NasdaqGS |
| Listing Date | June 19, 2001 | October 1, 2015 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of AXON and NVCR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | AXON | NVCR |
|---|---|---|
| 5-Day Price Return | 0.69% | -3.07% |
| 13-Week Price Return | 5.50% | -35.39% |
| 26-Week Price Return | 28.66% | -46.35% |
| 52-Week Price Return | 104.87% | -31.14% |
| Month-to-Date Return | 1.06% | 1.12% |
| Year-to-Date Return | 28.47% | -60.74% |
| 10-Day Avg. Volume | 0.62M | 1.39M |
| 3-Month Avg. Volume | 0.62M | 1.47M |
| 3-Month Volatility | 49.82% | 69.91% |
| Beta | 1.46 | 0.77 |
Profitability
Return on Equity (TTM)
AXON
13.43%
Aerospace & Defense Industry
- Max
- 43.89%
- Q3
- 22.42%
- Median
- 12.50%
- Q1
- 5.21%
- Min
- -6.24%
AXON’s Return on Equity of 13.43% is on par with the norm for the Aerospace & Defense industry, indicating its profitability relative to shareholder equity is typical for the sector.
NVCR
-45.46%
Health Care Equipment & Supplies Industry
- Max
- 34.53%
- Q3
- 19.38%
- Median
- 9.52%
- Q1
- 4.86%
- Min
- -7.58%
NVCR has a negative Return on Equity of -45.46%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
Net Profit Margin (TTM)
AXON
13.64%
Aerospace & Defense Industry
- Max
- 14.54%
- Q3
- 8.08%
- Median
- 6.17%
- Q1
- 2.49%
- Min
- -1.63%
A Net Profit Margin of 13.64% places AXON in the upper quartile for the Aerospace & Defense industry, signifying strong profitability and more effective cost management than most of its peers.
NVCR
-27.13%
Health Care Equipment & Supplies Industry
- Max
- 23.34%
- Q3
- 13.06%
- Median
- 9.53%
- Q1
- 5.96%
- Min
- -3.87%
NVCR has a negative Net Profit Margin of -27.13%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
Operating Profit Margin (TTM)
AXON
-1.26%
Aerospace & Defense Industry
- Max
- 16.63%
- Q3
- 10.38%
- Median
- 8.29%
- Q1
- 6.21%
- Min
- 0.95%
AXON has a negative Operating Profit Margin of -1.26%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
NVCR
-27.24%
Health Care Equipment & Supplies Industry
- Max
- 29.44%
- Q3
- 17.80%
- Median
- 13.95%
- Q1
- 8.73%
- Min
- -3.56%
NVCR has a negative Operating Profit Margin of -27.24%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
Profitability at a Glance
| Symbol | AXON | NVCR |
|---|---|---|
| Return on Equity (TTM) | 13.43% | -45.46% |
| Return on Assets (TTM) | 6.28% | -13.34% |
| Net Profit Margin (TTM) | 13.64% | -27.13% |
| Operating Profit Margin (TTM) | -1.26% | -27.24% |
| Gross Profit Margin (TTM) | 60.47% | 76.59% |
Financial Strength
Current Ratio (MRQ)
AXON
2.95
Aerospace & Defense Industry
- Max
- 3.09
- Q3
- 1.98
- Median
- 1.23
- Q1
- 1.03
- Min
- 0.02
AXON’s Current Ratio of 2.95 is in the upper quartile for the Aerospace & Defense industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
NVCR
1.47
Health Care Equipment & Supplies Industry
- Max
- 4.90
- Q3
- 3.05
- Median
- 2.14
- Q1
- 1.49
- Min
- 0.86
NVCR’s Current Ratio of 1.47 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
AXON
0.73
Aerospace & Defense Industry
- Max
- 1.70
- Q3
- 1.04
- Median
- 0.68
- Q1
- 0.41
- Min
- 0.00
AXON’s Debt-to-Equity Ratio of 0.73 is typical for the Aerospace & Defense industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
NVCR
1.81
Health Care Equipment & Supplies Industry
- Max
- 1.49
- Q3
- 0.71
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
With a Debt-to-Equity Ratio of 1.81, NVCR operates with exceptionally high leverage compared to the Health Care Equipment & Supplies industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
Interest Coverage Ratio (TTM)
AXON
888.35
Aerospace & Defense Industry
- Max
- 36.57
- Q3
- 19.90
- Median
- 7.04
- Q1
- 2.40
- Min
- -7.63
With an Interest Coverage Ratio of 888.35, AXON demonstrates a superior capacity to service its debt, placing it well above the typical range for the Aerospace & Defense industry. This stems from either robust earnings or a conservative debt load.
NVCR
-6.14
Health Care Equipment & Supplies Industry
- Max
- 58.29
- Q3
- 25.56
- Median
- 9.06
- Q1
- 3.60
- Min
- -28.92
NVCR has a negative Interest Coverage Ratio of -6.14. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
Financial Strength at a Glance
| Symbol | AXON | NVCR |
|---|---|---|
| Current Ratio (MRQ) | 2.95 | 1.47 |
| Quick Ratio (MRQ) | 2.56 | 1.41 |
| Debt-to-Equity Ratio (MRQ) | 0.73 | 1.81 |
| Interest Coverage Ratio (TTM) | 888.35 | -6.14 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
AXON
0.00%
Aerospace & Defense Industry
- Max
- 2.03%
- Q3
- 1.22%
- Median
- 0.43%
- Q1
- 0.00%
- Min
- 0.00%
AXON currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
NVCR
0.00%
Health Care Equipment & Supplies Industry
- Max
- 4.05%
- Q3
- 1.76%
- Median
- 0.71%
- Q1
- 0.00%
- Min
- 0.00%
NVCR currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
AXON
0.00%
Aerospace & Defense Industry
- Max
- 83.87%
- Q3
- 49.90%
- Median
- 16.48%
- Q1
- 0.00%
- Min
- 0.00%
AXON has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
NVCR
0.00%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 72.47%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
NVCR has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | AXON | NVCR |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
AXON
183.06
Aerospace & Defense Industry
- Max
- 65.97
- Q3
- 54.11
- Median
- 34.53
- Q1
- 23.66
- Min
- 0.00
At 183.06, AXON’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Aerospace & Defense industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.
NVCR
--
Health Care Equipment & Supplies Industry
- Max
- 73.48
- Q3
- 51.69
- Median
- 34.31
- Q1
- 25.74
- Min
- 11.47
P/E Ratio data for NVCR is currently unavailable.
Price-to-Sales Ratio (TTM)
AXON
24.98
Aerospace & Defense Industry
- Max
- 8.07
- Q3
- 4.49
- Median
- 2.42
- Q1
- 1.39
- Min
- 0.00
With a P/S Ratio of 24.98, AXON trades at a valuation that eclipses even the highest in the Aerospace & Defense industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
NVCR
2.11
Health Care Equipment & Supplies Industry
- Max
- 9.53
- Q3
- 5.26
- Median
- 3.39
- Q1
- 2.13
- Min
- 0.00
In the lower quartile for the Health Care Equipment & Supplies industry, NVCR’s P/S Ratio of 2.11 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
Price-to-Book Ratio (MRQ)
AXON
23.59
Aerospace & Defense Industry
- Max
- 13.67
- Q3
- 7.92
- Median
- 4.65
- Q1
- 2.68
- Min
- 0.82
At 23.59, AXON’s P/B Ratio is at an extreme premium to the Aerospace & Defense industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
NVCR
5.41
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 5.98
- Median
- 3.48
- Q1
- 2.43
- Min
- 0.69
NVCR’s P/B Ratio of 5.41 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | AXON | NVCR |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 183.06 | -- |
| Price-to-Sales Ratio (TTM) | 24.98 | 2.11 |
| Price-to-Book Ratio (MRQ) | 23.59 | 5.41 |
| Price-to-Free Cash Flow Ratio (TTM) | 164.74 | 46.58 |